Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma von Merz, Maximilian, Merz, Almuth Maria Anni, Wang, Jie, Wei, Lei, Hu, Qiang, Hutson, Nicholas, Rondeau, Cherie, Celotto, Kimberly, Belal, Ahmed, Alberico, Ronald, Block, AnneMarie W., Mohammadpour, Hemn, Wallace, Paul K., Tario, Joseph, Luce, Jesse, Glenn, Sean T., Singh, Prashant, Herr, Megan M., Hahn, Theresa, Samur, Mehmet, Munshi, Nikhil, Liu, Song, McCarthy, Philip L., Hillengass, Jens

Volltext

Functional cure and long-term survival in multiple myeloma: how to challenge the previously impossible von Engelhardt, Monika, Kortüm, K Martin, Goldschmidt, Hartmut, Merz, Maximilian

Volltext

Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes von Kortüm, K.Martin, Mai, Elias K., Hanafiah, Nur H., Shi, Chang-Xi, Zhu, Yuan-Xiao, Bruins, Laura, Barrio, Santiago, Jedlowski, Patrick, Merz, Maximilian, Xu, Jing, Stewart, Robert A., Andrulis, Mindaugas, Jauch, Anna, Hillengass, Jens, Goldschmidt, Hartmut, Bergsagel, P.Leif, Braggio, Esteban, Stewart, A.Keith, Raab, Marc S.

Volltext

The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma von Merz, Maximilian, Dechow, Tobias, Scheytt, Mithun, Schmidt, Christian, Hackanson, Bjoern, Knop, Stefan

Volltext

Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma von Merz, Maximilian, Hielscher, Thomas, Schult, David, Mai, Elias K., Raab, Marc S., Hillengass, Jens, Seckinger, Anja, Hose, Dirk, Granzow, Martin, Jauch, Anna, Goldschmidt, Hartmut

Volltext

Characterization of the major autolysin (AtlC) of Staphylococcus carnosus von Merz, Maximilian, Schiffer, Carolin J, Klingl, Andreas, Ehrmann, Matthias A

Volltext

A time-resolved meta-analysis of consensus gene expression profiles during human T-cell activation von Rade, Michael, Böhlen, Sebastian, Neuhaus, Vanessa, Löffler, Dennis, Blumert, Conny, Merz, Maximilian, Köhl, Ulrike, Dehmel, Susann, Sewald, Katherina, Reiche, Kristin

Volltext

Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial von Goldschmidt, Hartmut, Mai, Elias K., Dürig, Jan, Scheid, Christof, Weisel, Katja C., Kunz, Christina, Bertsch, Uta, Hielscher, Thomas, Merz, Maximilian, Munder, Markus, Lindemann, Hans-Walter, Hügle-Dörr, Barbara, Tichy, Diana, Giesen, Nicola, Hose, Dirk, Seckinger, Anja, Huhn, Stefanie, Luntz, Steffen, Jauch, Anna, Elmaagacli, Ahmet, Rabold, Bernhard, Fuhrmann, Stephan, Brossart, Peter, Goerner, Martin, Bernhard, Helga, Hoffmann, Martin, Hillengass, Jens, Raab, Marc S., Blau, Igor W., Hänel, Mathias, Salwender, Hans J.

Volltext

The prognostic significance of [18F]FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs) von Sachpekidis, Christos, Merz, Maximilian, Raab, Marc-Steffen, Bertsch, Uta, Weru, Vivienn, Kopp-Schneider, Annette, Jauch, Anna, Goldschmidt, Hartmut, Dimitrakopoulou-Strauss, Antonia

Volltext

Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation von Jentzsch, Madlen, Bischof, Lara, Ussmann, Jule, Backhaus, Donata, Brauer, Dominic, Metzeler, Klaus H., Merz, Maximilian, Vucinic, Vladan, Franke, Georg-Nikolaus, Herling, Marco, Platzbecker, Uwe, Schwind, Sebastian

Volltext

Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age von Mai, Elias K., Miah, Kaya, Bertsch, Uta, Dürig, Jan, Scheid, Christof, Weisel, Katja C., Kunz, Christina, Munder, Markus, Lindemann, Hans-Walter, Merz, Maximilian, Hose, Dirk, Jauch, Anna, Seckinger, Anja, Luntz, Steffen, Sauer, Sandra, Fuhrmann, Stephan, Brossart, Peter, Elmaagacli, Ahmet, Goerner, Martin, Bernhard, Helga, Hoffmann, Martin, Raab, Marc S., Blau, Igor W., Hänel, Mathias, Benner, Axel, Salwender, Hans J., Goldschmidt, Hartmut

Volltext

Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE‐MRI in a longitudinal in vivo study von Bäuerle, Tobias, Komljenovic, Dorde, Merz, Maximilian, Berger, Martin R., Goodman, Simon L., Semmler, Wolfhard

Volltext

Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial von Salwender, Hans, Elmaagacli, Ahmet, Merz, Maximilian, Miah, Kaya, Benner, Axel, Haenel, Mathias, Jehn, Christian, Mai, Elias K., Bertsch, Uta, Blau, Igor W., Scheid, Christof, Hose, Dirk, Seckinger, Anja, Jauch, Anna, Raab, Marc S., Luntz, Steffen P., Besemer, Britta, Munder, Markus, Brossart, Peter, Fuhrmann, Stephan, Lindemann, Hans-Walter, Weisel, Katja, Duerig, Jan, Goldschmidt, Hartmut

Volltext

Chemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patients von Mahmoudpour, Seyed Hamidreza, Bandapalli, Obul Reddy, da Silva Filho, Miguel Inácio, Campo, Chiara, Hemminki, Kari, Goldschmidt, Hartmut, Merz, Maximilian, Försti, Asta

Volltext

Fast and furious: Changing gears on the road to cure with chimeric antigen receptor T cells in multiple myeloma von Gagelmann, Nico, Merz, Maximilian

Volltext

A comeback for checkpoint inhibition in multiple myeloma von Merz, Maximilian

Volltext

Publisher Correction: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age von Mai, Elias K., Miah, Kaya, Bertsch, Uta, Dürig, Jan, Scheid, Christof, Weisel, Katja C., Kunz, Christina, Munder, Markus, Lindemann, Hans-Walter, Merz, Maximilian, Hose, Dirk, Jauch, Anna, Seckinger, Anja, Luntz, Steffen, Sauer, Sandra, Fuhrmann, Stephan, Brossart, Peter, Elmaagacli, Ahmet, Goerner, Martin, Bernhard, Helga, Hoffmann, Martin, Raab, Marc S., Blau, Igor W., Hänel, Mathias, Benner, Axel, Salwender, Hans J., Goldschmidt, Hartmut

Volltext

Cytogenetic aberrations in multiple myeloma are associated with shifts in serum immunoglobulin isotypes distribution and levels von Yadav, Pankaj, Merz, Maximilian, Mai, Elias K, Försti, Asta, Jauch, Anna, Goldschmidt, Hartmut, Hemminki, Kari

Volltext

Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial von Salwender, Hans, Weinhold, Niels, Benner, Axel, Miah, Kaya, Merz, Maximilian, Haenel, Mathias, Jehn, Christian, Mai, Elias, Menis, Ekaterina, Blau, Igor, Scheid, Christof, Hose, Dirk, Seckinger, Anja, Luntz, Steffen, Besemer, Britta, Munder, Markus, Brossart, Peter, Glass, Bertram, Lindemann, Hans-Walter, Weisel, Katja, Hanoun, Christine, Schnitzler, Paul, Klemm, Sarah, Goldschmidt, Hartmut, Raab, Marc, Elmaagacli, Ahmet

Volltext

Diffusion-Weighted MRI—The Way Forward for MRI in Myeloma? von Hillengass, Jens, Merz, Maximilian, Alberico, Ronald, Chalian, Majid

Volltext